Platelets in patients with premature coronary artery disease exhibit upregulation of mirna340 * and mirna624 *

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Sondermeijer, Brigitte M ^a   Bakker, Annemieke ^a   Halliani, Amalia ^a   de Ronde, Maurice W J ^a   Marquart, Arnoud A ^a   Tijsen, Anke J ^a   Mulders, Ties A ^a   Kok, Maayke G M ^a   Battjes, Suzanne ^a   Maiwald, Steffi ^a   Sivapalaratnam, Suthesh ^a   Trip, Mieke D ^a   Moerland, Perry D ^a   Meijers, Joost C M ^a   Creemers, Esther E ^a   Pinto Sietsma, Sara Joan ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 1280; MICRORNA 340; MICRORNA 451; MICRORNA 454; MICRORNA 545; MICRORNA 615 5P; MICRORNA 624; UNCLASSIFIED DRUG; MIRN340 MICRORNA, HUMAN; MIRN624 MICRORNA, HUMAN;

ADULT; ARTICLE; CASE CONTROL STUDY; CELL FUNCTION; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE COURSE; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE LOCATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; ONSET AGE; RNA ANALYSIS; THROMBOCYTE; UPREGULATION; VALIDATION PROCESS; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETICS; METABOLISM; MIDDLE AGED; REPRODUCIBILITY;

ADULT; BLOOD PLATELETS; CASE-CONTROL STUDIES; COHORT STUDIES; CORONARY ARTERY DISEASE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MICRORNAS; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; UP-REGULATION;

EID: 80054085814     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025946     Document Type: Article

References (36)

1. Ferket BS, Colkesen EB, Visser JJ, Spronk S, Kraaijenhagen RA, et al. (2010) Systematic review of guidelines on cardiovascular risk assessment: Which recommendations should clinicians follow for a cardiovascular health check? Arch Intern Med 170: 27-40.
2. Greenland P, Smith SC Jr, Grundy SM, (2001) Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. Circulation 104: 1863-1867.
3. Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, et al. (2003) Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 290: 891-897.
4. Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, et al. (2003) Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 290: 898-904.
5. Erson AE, Petty EM, (2008) MicroRNAs in development and disease. Clin Genet 74: 296-306.
6. Zhang C, (2008) MicroRNomics: a newly emerging approach for disease biology. Physiol Genomics 33: 139-147.
7. Calin GA, Croce CM, (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
8. van RE, Olson EN, (2007) MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest 117: 2369-2376.
9. Tijsen AJ, Creemers EE, Moerland PD, de Windt LJ, van der Wal AC, et al. (2010) MiR423-5p As a Circulating Biomarker for Heart Failure. Circ Res 106: 1035-1039.
10. Chiang HR, Schoenfeld LW, Ruby JG, Auyeung VC, Spies N, et al. (2010) Mammalian microRNAs: experimental evaluation of novel and previously annotated genes. Genes Dev 24: 992-1009.
11. Chen CZ, Li L, Lodish HF, Bartel DP, (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86.
12. Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, et al. (2005) Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37: 766-770.
13. Lu J, Getz G, Miska EA, varez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
14. Wienholds E, Plasterk RH, (2005) MicroRNA function in animal development. FEBS Lett 579: 5911-5922.
15. Davi G, Patrono C, (2007) Platelet activation and atherothrombosis. N Engl J Med 357: 2482-2494.
16. Landry P, Plante I, Ouellet DL, Perron MP, Rousseau G, et al. (2009) Existence of a microRNA pathway in anucleate platelets. Nat Struct Mol Biol 16: 961-966.
17. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, et al. (2008) Serum microRNAs are promising novel biomarkers. PLoS One 3: e3148.
18. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
19. Chen SY, Wang Y, Telen MJ, Chi JT, (2008) The genomic analysis of erythrocyte microRNA expression in sickle cell diseases. PLoS One 3: e2360.
20. Bruchova H, Merkerova M, Prchal JT, (2008) Aberrant expression of microRNA in polycythemia vera. Haematologica 93: 1009-1016.
21. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, et al. (2008) Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 3: e3694.
22. Merkerova M, Belickova M, Bruchova H, (2008) Differential expression of microRNAs in hematopoietic cell lineages. Eur J Haematol 81: 304-310.
23. Scheuner MT, (2001) Genetic predisposition to coronary artery disease. Curr Opin Cardiol 16: 251-260.
24. Rodrigues AC, Li X, Radecki L, Pan YZ, Winter JC, et al. (MicroRNA expression is differentially altered by xenobiotic drugs in different human cell lines.
25. Weber M, Baker MB, Patel RS, Quyyumi AA, Bao G, et al. (2011) MicroRNA Expression Profile in CAD Patients and the Impact of ACEI/ARB. Cardiol Res Pract 2011.
26. Arad Y, Goodman KJ, Roth M, Newstein D, Guerci AD, (2005) Coronary Calcification, Coronary Disease Risk Factors, C-Reactive Protein, and Atherosclerotic Cardiovascular Disease Events: The St. Francis Heart Study. Journal of the American College of Cardiology 46: 158-165.
27. Ai J, Zhang R, Li Y, Pu J, Lu Y, et al. (2009) Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun.
28. Adachi T, Nakanishi M, Otsuka Y, Nishimura K, Hirokawa G, et al. (2010) Plasma MicroRNA 499 as a Biomarker of Acute Myocardial Infarction. Clin Chem 56: 1183-1185.
29. Meder B, Keller A, Vogel B, Haas J, Sedaghat-Hamedani F, et al. (2011) MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction. Basic Research in Cardiology 106: 13-23.
30. Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, et al. (2010) Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease/Clinical Perspective. Circulation: Cardiovascular Genetics 3: 499-506.
31. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, et al. (2010) Circulating MicroRNAs in Patients With Coronary Artery Disease. Circ Res 107: 677-684.
32. Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y, et al. (2009) Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 55: 1944-1949.
33. Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, et al. (2010) Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. European Heart Journal 31: 659-666.
34. Cheng Y, Tan N, Yang J, Liu X, Cao X, et al. (2010) A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin Sci 119: 87-95.
35. Bostjancic E, Zidar N, Stajer D, Glavac D, (2009) MicroRNAs miR-1, miR-133a, miR-133b and miR-208 Are Dysregulated in Human Myocardial Infarction. Cardiology 115: 163-169.
36. Murphy TP, Dhangana R, Pencina MJ, Zafar AM, D'Agostino RB, (Performance of current guidelines for coronary heart disease prevention: Optimal use of the Framingham-based risk assessment. Atherosclerosis In Press, Corrected Proof.